Brief: Kenneth Griffin Reports Passive Stake Of 5.2% In Pieris Pharmaceuticals Inc As Of June 25, 2021
July 6 (Reuters) - Pieris Pharmaceuticals Inc PIRS.O :
* KENNETH GRIFFIN REPORTS PASSIVE STAKE OF 5.2% IN PIERIS
PHARMACEUTICALS INC AS OF JUNE 25, 2021 - SEC FILING
Further company coverage: PIRS.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Palvella Therapeutics
See all newsPalvella Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Palvella Therapeutics Q2 net loss widens on higher expenses
Brief: Palvella Therapeutics Announces New Data From The Phase 2 Toiva Trial Of Qtorin™ Rapamycin In Cutaneous Venous Malformations
Brief: Palvella Therapeutics Announces Uplisting To The Nasdaq Global Market
Palvella Therapeutics' Q1 net loss widens on higher costs